GSK-3 Inhibitor IX CAS: 667463-62-9
MF: C16H10BrN3O2
MW: 356.17

GSK-3 Inhibitor IX (CAS 667463-62-9)

GSK-3 Inhibitor IX | CAS 667463-62-9 is rated 5.0 out of 5 by 1.
  • y_2020, m_10, d_18, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202634, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 98ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: GSK-3 Inhibitor IX is also known as BIO.
Application: GSK-3 Inhibitor IX is a cell-permeable, highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α and GSK-3β.
CAS Number: 667463-62-9
Purity: >97%
Molecular Weight: 356.17
Molecular Formula: C16H10BrN3O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

GSK-3 Inhibitor IX (BIO) is a cell-permeable, highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α and GSK-3β (IC50 = 5 nM). GSK-3 (Glycogen synthase kinase-3) plays important roles in numerous signaling pathways that regulate a variety of cellular processes including cell proliferation, differentiation, apoptosis and embryonic development. GSK-3 Inhibitor IX also inhibits PKB Kinase (phosphoinositide-dependent kinase 1; PDK1 or PDPK1), a master kinase responsible for the activation of AKT/PKB, PKC, p70 S6 kinase (S6K) and SGK (serum/glucocorticoid regulated kinase). Research shows that PKB Kinase inhibition halts endothelial cell migration. GSK-3 Inhibitor IX has been been widely-used in embryonic stem cell studies to maintain human embryonic stem cells in their undifferentiated state, and to sustain expression of the pluripotent state-specific transcription factors Oct-3/4, Rex-1 and Nanog. GSK-3 Inhibitor IX has been shown to induce the differentiation of neonatal cardiomyocytes and maintain self-renewal in both human and mouse embryonic stem cells through wnt signaling activation.


References

1. Meijer, Laurent., et al., 2003. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chemistry & biology. 10(12): 1255-66. PMID: 14700633

2. Polychronopoulos, Panagiotis., et al., 2004. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. Journal of medicinal chemistry. 47(4): 935-46. PMID: 14761195

3. Tseng, Ai-Sun., et al., 2006. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chemistry & biology. 13(9): 957-63. PMID: 16984885

4. Zahler, Stefan., et al., 2007. Inverse in silico screening for identification of kinase inhibitor targets. Chemistry & biology. 14(11): 1207-14. PMID: 18022559

5. Xu, Chong., et al., 2009. Regulation of protein stability by GSK3 mediated phosphorylation. Cell cycle (Georgetown, Tex.). 8(24): 4032-9. PMID: 19923896

6. Rasola, Andrea., et al., 2010. Signal transduction to the permeability transition pore. FEBS letters. 584(10): 1989-96. PMID: 20153328

7. Spokoini, Rachel., et al., 2010. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Molecular endocrinology (Baltimore, Md.). 24(6): 1136-50. PMID: 20371704

8. Fairbairn, E.A. et al. 2012. Aquat. Toxicol. 124-125 : 188-196. PMID: 22975441

Physical State :
Solid
Solubility :
Soluble in DMSO ( >5 mg/ml), ethanol (10 mM), DMF (10 mg/ml), and 1:2 DMSO:PBS (pH 7.2) (~0.3 mg/ml).
Storage :
Store at 4° C
Boiling Point :
~554.26° C at 760 mmHg (Predicted)
Density :
~1.80 g/cm3 (Predicted)
Refractive Index :
n20D 1.80 (Predicted)
IC50 :
GSK-3α/β: IC50 = 5 nM; Cdk5/p25: IC50 = 83 nM; Cdk2/A: IC50 = 300 nM; Cdk1/B: IC50 = 320 nM; Cdk4/D1: IC50 = 10 µM
pK Values :
pKa: 9.56 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
PubChem CID :
5287844
MDL Number :
MFCD08705318
SMILES :
C1=CC2=C(/C(=C/3\\C4=C(C=C(C=C4)Br)NC3=O)/N=C2C=C1)NO

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

GSK-3 Inhibitor IX (CAS 667463-62-9)  Product Citations

See how others have used GSK-3 Inhibitor IX (CAS 667463-62-9). Click on the entry to view the PubMed entry .

Citations 1 to 7 of 7 total

PMID: # 30388586  2019. Spectrochim Acta A Mol Biomol Spectrosc. 209: 150-164.

PMID: # 30984989  2019. Turk Neurosurg. 29: 513-521.

PMID: # 30412805  2019. J Pharm Biomed Anal. 164: 317-325.

PMID: # 26831110  Iovino, S.|Burkart, AM.|Warren, L.|Patti, ME.|Kahn, CR.| et al. 2016. Proc. Natl. Acad. Sci. U.S.A. 113: 1889-94.

PMID: # 27997540  Li, Y. et al. 2016. PLoS Med. 13: e1002200.

PMID: # 22574208  Shao, M. et al. 2012. PLoS ONE. 7: e36655.

PMID: # 32430065  Biol. Res. 53: 22.

Citations 1 to 7 of 7 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 112ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Fairbaim et al Fairbaim et al. (PubMed ID 22975441) found that GSK-3 Inhibitor IX caused morphological abnormalities in zebrafish embryos by increasing nuclear Beta-catenin throughout the embryo. -SCBT Publication Review
Date published: 2015-02-24
  • y_2020, m_10, d_18, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202634, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 12ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.